Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Online Network.
Press releases published on June 26, 2025
Lifeward Announces Closing of $2.6 Million Public Offering
GlobeNewswire
·
June 26, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising
GlobeNewswire
·
June 26, 2025
Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company’s initial public offering, has granted its …
Norwegian Cruise Line Holdings Announces Upsize of its Revolving Credit Facility
GlobeNewswire
·
June 26, 2025
MIAMI, June 26, 2025 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings” or the “Company”) announced that it has successfully upsized its existing senior secured …
Herbal Dietary Supplement Market Trends, Active Key Players, and Growth Projection Up to 2032
EIN Presswire
·
June 26, 2025
Increasing global demand for natural health solutions and herbal supplements to enhance well-being is projected to drive the global market’s growth. WILMINGTON, DE, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Herbal dietary supplement market size …
Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
GlobeNewswire
·
June 26, 2025
TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on Friday, August 1, 2025, before the U.S. financial markets open. …
Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel
GlobeNewswire
·
June 26, 2025
Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of 2026 Tech transfer underway with validation batch …
Diabetic Macular Edema Treatment 2025: From Monthly Injections to Dual-Action, Longer-Lasting Solutions
EIN Presswire
·
June 26, 2025
DME care is evolving-dual-target biologics, sustained-release systems and AI diagnostics aim to improve vision outcomes, reduce visits, and expand global access AUSTIN, TX, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Diabetic Macular Edema (DME) …
Healthcare Staffing Market Set to Witness Significant Growth by 2025-2032: Adecco, TeamHealth, Trustaff, Aya Healthcare
EIN Presswire
·
June 26, 2025
BURLINGAME, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- The Healthcare Staffing Industry continues to undergo significant transformation, driven by increasing demand for flexible and specialized medical workforce solutions globally. As …
Retinal Vein Occlusion (RVO): A Market on the Verge of Therapeutic Breakthrough | Competitive Intelligence
EIN Presswire
·
June 26, 2025
RVO management is evolving-longer-acting dual-target biologics, improved safety profiles, and global-access strategies are set to redefine macular edema therapy AUSTIN, TX, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Retinal Vein Occlusion (RVO) …
Achieve Life Sciences Announces Proposed Underwritten Public Offering
GlobeNewswire
·
June 26, 2025
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Europe IV Hydration Therapy Market Set to Witness Significant Growth by 2025-2032: Sechoir, ELIXIR, Swiss Medical Centre
EIN Presswire
·
June 26, 2025
BURLINGAME, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- The Europe IV Hydration Therapy industry is undergoing rapid expansion, driven by growing awareness of wellness and preventive healthcare. Increasing adoption across sports medicine, …
Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades
GlobeNewswire
·
June 26, 2025
Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to enable a faster, smarter, and more effective path to address a critical …
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
GlobeNewswire
·
June 26, 2025
Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved pharmacotherapy option for nicotine dependence in two decades More …
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
GlobeNewswire
·
June 26, 2025
WAYNE, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide a …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 26, 2025
VANCOUVER, British Columbia and BOSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
CorMedix Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
June 26, 2025
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it intends …
INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
GlobeNewswire
·
June 26, 2025
Company to host a conference call to discuss results at 8:00am EDT on June 30, 2025 Boca Raton, Florida, June 26, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, will host a …
Cell Culture Media Market Report 2025-2035: Competitive Landscape and Revenue Breakdown
EIN Presswire
·
June 26, 2025
PORTLAND, IN, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, “Cell Culture Media Market by Type (Natural Media, Artificial Media), by Application (Biopharmaceutical Production, Regenerative Medicine …
Zest: Helping Parents-to-Be Optimize Their Health and Fertility with Functional Age Testing
EIN Presswire
·
June 26, 2025
June is Infertility Awareness Month: Dr. Julia Cooney highlights how functional age testing can support couples in their pre-conception journey LONDON, MA, UNITED KINGDOM, June 26, 2025 /EINPresswire.com/ -- As awareness grows around the importance of …
America's Blood Centers Honors HOSA-Future Health Professionals Lifesaving Impact at 2025 International Leadership Conference
GlobeNewswire
·
June 26, 2025
Washington, DC, June 26, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, honored HOSA-Future Health Professionals chapters …